Semler Scientific Shares Fall After Disclosing US DOJ Probe Into Potential False Claims Act Violations

MT Newswires Live
03-04

Semler Scientific (SMLR) shares fell 4.9% in recent Monday trading after the company disclosed in a regulatory filing last Friday that the US Department of Justice is investigating whether it violated the federal False Claims Act by marketing tests on devices that use photoplethysmography technology as reimbursable by Medicare.

The company said it began initial settlement discussions with the DOJ on Feb. 11 but ceased the talks on the same day.

"Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages," Semler said in the filing. "We do not believe the amount of loss can be reasonably estimated."

Price: 40.82, Change: -2.10, Percent Change: -4.89

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10